The effect of recombinant stromal cell-derived factor-1 treatment on hypoxic-ischemic brain injury in neonatal mice

Neuropediatrics

Volumn 43, Issue 6, 2012, Pages 320-331

  Zhu, Weiwei ^a   Ma, Xiaoli ^a   Li, Feng ^a   Wang, Jun ^a   Yu, Lichun ^a   Xu, Mi ^a   Ma, Aihua ^a   Guo, Aili ^a   Zhang, Nan ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

apoptosis; functional recovery; hypoxia ischemia brain injury; neonatal mice; proliferation; stromal cell derived factor 1

Indexed keywords

CASPASE 3; KI 67 ANTIGEN; RECOMBINANT CYTOKINE; RECOMBINANT STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARM; ARTICLE; BODY WEIGHT; BRAIN; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LATENT PERIOD; LEFT HEMISPHERE; MAZE TEST; MOUSE; NEWBORN; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIGHT HEMISPHERE; SHAM PROCEDURE; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; AVOIDANCE LEARNING; BRAIN; CASPASE 3; CHEMOKINE CXCL12; DISEASE MODELS, ANIMAL; HYPOXIA-ISCHEMIA, BRAIN; KI-67 ANTIGEN; MICE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 84870237972     PISSN: 0174304X     EISSN: 14391899     Source Type: Journal    
DOI: 10.1055/s-0032-1325121     Document Type: Article

References (52)

1. Graham E. M., Ruis K. A., Hartman A. L., Northington F. J., Fox H. E. A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol: 2008; 199 6 587 595
2. Vannucci R. C. Hypoxic-ischemic encephalopathy. Am J Perinatol: 2000; 17 3 113 120
3. Imitola J., Raddassi K., Park K. I., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A: 2004; 101 52 18117 18122 (Pubitemid 40054083)
4. Lazarini F., Tham T. N., Casanova P., Arenzana-Seisdedos F., Dubois-Dalcq M. Role of the α-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia: 2003; 42 2 139 148 (Pubitemid 36565118)
5. Li M., Ransohoff R. M. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol: 2008; 84 2 116 131
6. Peng H., Huang Y., Rose J., et al. Stromal cell-derived factor 1-mediated CXCR4 signaling in rat and human cortical neural progenitor cells. J Neurosci Res: 2004; 76 1 35 50 (Pubitemid 38445562)
7. Lu M., Grove E. A., Miller R. J. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci U S A: 2002; 99 10 7090 7095 (Pubitemid 34526260)
8. Tissir F., Wang C. E., Goffinet A. M. Expression of the chemokine receptor Cxcr4 mRNA during mouse brain development. Brain Res Dev Brain Res: 2004; 149 1 63 71 (Pubitemid 38315063)
9. Tran P. B., Ren D., Veldhouse T. J., Miller R. J. Chemokine receptors are expressed widely by embryonic and adult neural progenitor cells. J Neurosci Res: 2004; 76 1 20 34 (Pubitemid 38445561)
10. Ceradini D. J., Kulkarni A. R., Callaghan M. J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med: 2004; 10 8 858 864 (Pubitemid 39070860)
11. Shyu W. C., Lin S. Z., Yen P. S., et al. Stromal cell-derived factor-1 α promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats. J Pharmacol Exp Ther: 2008; 324 2 834 849
12. Wang Y., Deng Y. B., Zhou G. Q. SDF-1α/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res: 2008; 1195 104 112
13. Hiasa K., Ishibashi M., Ohtani K., et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation: 2004; 109 20 2454 2461 (Pubitemid 38679567)
14. Yamaguchi J., Kusano K. F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation: 2003; 107 9 1322 1328 (Pubitemid 36314418)
15. Ji J. F., He B. P., Dheen S. T., Tay S. S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells: 2004; 22 3 415 427 (Pubitemid 38736625)
16. Ni H. T., Hu S., Sheng W. S., et al. High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev Brain Res: 2004; 152 2 159 169 (Pubitemid 39194831)
17. Peng Y., Jiang B. H., Yang P. H., et al. Phosphatidylinositol 3-kinase signaling is involved in neurogenesis during Xenopus embryonic development. J Biol Chem: 2004; 279 27 28509 28514 (Pubitemid 38900133)
18. Miller J. T., Bartley J. H., Wimborne H. J., et al. The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci: 2005; 6 63
19. Taniguchi H., Mohri I., Okabe-Arahori H., et al. Prostaglandin D2 protects neonatal mouse brain from hypoxic ischemic injury. J Neurosci: 2007; 27 16 4303 4312 (Pubitemid 46640702)
20. Kerfoot S. M., Andonegui G., Bonder C. S., Liu L. Exogenous stromal cell-derived factor-1 induces modest leukocyte recruitment in vivo. Am J Physiol Heart Circ Physiol: 2008; 294 6 H2524 H2534
21. Rice J. E. III, Vannucci R. C., Brierley J. B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol: 1981; 9 2 131 141 (Pubitemid 11191192)
22. Yuan J. S., Reed A., Chen F., Stewart C. N. Jr. Statistical analysis of real-time PCR data. BMC Bioinformatics: 2006; 7 85
23. Jing H., Ai-Rong Q., Li-Fang H., et al. Semi-quantitative analysis methods of tubulin based on the fluorescent images. J Fourth Mil Med Univ.: 2009; 30 24
24. Fan L. W., Lin S., Pang Y., et al. Hypoxia-ischemia induced neurological dysfunction and brain injury in the neonatal rat. Behav Brain Res: 2005; 165 1 80 90 (Pubitemid 41476207)
25. Sasaki K., Fan L. W., Tien L. T., Ma T., Loh H. H., Ho I. K. The interaction of morphine and gamma-aminobutyric acid (GABA)ergic systems in anxiolytic behavior: using mu-opioid receptor knockout mice. Brain Res Bull: 2002; 57 5 689 694 (Pubitemid 34240416)
26. Corti S., Locatelli F., Papadimitriou D., et al. Multipotentiality, homing properties, and pyramidal neurogenesis of CNS-derived LeX(ssea-1)+/CXCR4+ stem cells. FASEB J: 2005; 19 13 1860 1862 (Pubitemid 41598775)
27. Shichinohe H., Kuroda S., Yano S., Hida K., Iwasaki Y. Role of SDF-1/CXCR4 system in survival and migration of bone marrow stromal cells after transplantation into mice cerebral infarct. Brain Res: 2007; 1183 138 147 (Pubitemid 350088692)
28. Calvert J. W., Yin W., Patel M., et al. Hyperbaric oxygenation prevented brain injury induced by hypoxia-ischemia in a neonatal rat model. Brain Res: 2002; 951 1 1 8 (Pubitemid 35253890)
29. Hermans R. H., Hunter D. E., McGivern R. F., Cain C. D., Longo L. D. Behavioral sequelae in young rats of acute intermittent antenatal hypoxia. Neurotoxicol Teratol: 1992; 14 2 119 129
30. Agmo A., Belzung C. The role of subtypes of the opioid receptor in the anxiolytic action of chlordiazepoxide. Neuropharmacology: 1998; 37 2 223 232 (Pubitemid 28293761)
31. Schmitt U., Lüddens H., Hiemke C. Anxiolytic-like effects of acute and chronic GABA transporter inhibition in rats. J Neural Transm: 2002; 109 5-6 871 880 (Pubitemid 34810779)
32. Mirshahi F., Pourtau J., Li H., et al. SDF-1 activity on microvascular endothelial cells: consequences on angiogenesis in in vitro and in vivo models. Thromb Res: 2000; 99 6 587 594 (Pubitemid 30642740)
33. Aiuti A., Webb I. J., Bleul C., Springer T., Gutierrez-Ramos J. C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med: 1997; 185 1 111 120 (Pubitemid 27039446)
34. Bleul C. C., Fuhlbrigge R. C., Casasnovas J. M., Aiuti A., Springer T. A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med: 1996; 184 3 1101 1109 (Pubitemid 26313567)
35. Hill W. D., Hess D. C., Martin-Studdard A., et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol: 2004; 63 1 84 96 (Pubitemid 38030236)
36. Kokovay E., Goderie S., Wang Y., et al. Adult SVZ lineage cells home to and leave the vascular niche via differential responses to SDF1/CXCR4 signaling. Cell Stem Cell: 2010; 7 2 163 173
37. Tabatabai G., Bähr O., Möhle R., et al. Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells. Brain: 2005; 128 Pt 9 2200 2211 (Pubitemid 41253286)
38. Teicher B. A., Fricker S. P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res: 2010; 16 11 2927 2931
39. Guo Y., Hangoc G., Bian H., Pelus L. M., Broxmeyer H. E. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells: 2005; 23 9 1324 1332 (Pubitemid 41504920)
40. West T., Atzeva M., Holtzman D. M. Caspase-3 deficiency during development increases vulnerability to hypoxic-ischemic injury through caspase-3-independent pathways. Neurobiol Dis: 2006; 22 3 523 537 (Pubitemid 43832124)
41. Fukunaga K., Kawano T. Akt is a molecular target for signal transduction therapy in brain ischemic insult. J Pharmacol Sci: 2003; 92 4 317 327 (Pubitemid 37098256)
42. Tomimatsu T., Fukuda H., Endo M., et al. Effects of hypothermia on neonatal hypoxic-ischemic brain injury in the rat: phosphorylation of Akt, activation of caspase-3-like protease. Neurosci Lett: 2001; 312 1 21 24 (Pubitemid 32907543)
43. do Carmo A., Patricio I., Cruz M. T., Carvalheiro H., Oliveira C. R., Lopes M. C. CXCL12/CXCR4 promotes motility and proliferation of glioma cells. Cancer Biol Ther: 2010; 9 1 56 65
44. Yang Z., Levison S. W. Hypoxia/ischemia expands the regenerative capacity of progenitors in the perinatal subventricular zone. Neuroscience: 2006; 139 2 555 564
45. Plane J. M., Liu R., Wang T. W., Silverstein F. S., Parent J. M. Neonatal hypoxic-ischemic injury increases forebrain subventricular zone neurogenesis in the mouse. Neurobiol Dis: 2004; 16 3 585 595 (Pubitemid 38942992)
46. Bonavia R., Bajetto A., Barbero S., Pirani P., Florio T., Schettini G. Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation. Toxicol Lett: 2003; 139 2-3 181 189 (Pubitemid 36298976)
47. Yang Z., Levison S. W. Perinatal hypoxic/ischemic brain injury induces persistent production of striatal neurons from subventricular zone progenitors. Dev Neurosci: 2007; 29 4-5 331 340 (Pubitemid 47343687)
48. Felling R. J., Snyder M. J., Romanko M. J., et al. Neural stem/progenitor cells participate in the regenerative response to perinatal hypoxia/ischemia. J Neurosci: 2006; 26 16 4359 4369 (Pubitemid 44315395)
49. Miles D. K., Kernie S. G. Hypoxic-ischemic brain injury activates early hippocampal stem/progenitor cells to replace vulnerable neuroblasts. Hippocampus: 2008; 18 8 793 806
50. Sung S. M., Jung D. S., Kwon C. H., Park J. Y., Kang S. K., Kim Y. K. Hypoxia/reoxygenation stimulates proliferation through PKC-dependent activation of ERK and Akt in mouse neural progenitor cells. Neurochem Res: 2007; 32 11 1932 1939 (Pubitemid 47497896)
51. Otaegi G., Yusta-Boyo M. J., Vergaño-Vera E., et al. Modulation of the PI 3-kinase-Akt signalling pathway by IGF-I and PTEN regulates the differentiation of neural stem/precursor cells. J Cell Sci: 2006; 119 Pt 13 2739 2748 (Pubitemid 44184010)
52. Yano T., Liu Z., Donovan J., Thomas M. K., Habener J. F. Stromal cell derived factor-1 (SDF-1)/CXCL12 attenuates diabetes in mice and promotes pancreatic beta-cell survival by activation of the prosurvival kinase Akt. Diabetes: 2007; 56 12 2946 2957 (Pubitemid 350223629)